daniela zinzi

VP, Clinical R&D at F2G
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
IT
Languages
  • Italiano Native or bilingual proficiency
  • English Professional working proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

5.0

/5.0
/ Based on 2 ratings
  • (2)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

Marco Guazzini

I had the opportunity to meet and work with Daniela during my 2 years time at Menarini company; we worked together during the set-up of the newly created Infectious Disease (ID) business unit. The expertise Daniela played both with top class scientific and organizational skills was really appreciated. Spending time together, with extensive travelling, working with KOLs, setting up new value statements while creating this ID new identity for the company, demonstrated me her unique industry expertise, reputation and recognition from her peers. She has high passion for her job, in everything she does; she is great in working with people, navigating among complex tasks with one the of the highest scientific and business oriented acumen I ever seen. I see all of these as key added values she would add to whatever business as well, no matter the specific therapeutic area she would be assigned to.

Davide Piras

Daniela demonstrated very deep scientific knowledge and ability to work in Team. Her enthusiasm and motivation created positive energy and accelerated the achievement of results.

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United Kingdom
    • Biotechnology Research
    • 1 - 100 Employee
    • VP, Clinical R&D
      • Jan 2023 - Present

    • Executive Director, Clinical R&D
      • Jul 2021 - Feb 2023

    • Expert
      • Dec 2022 - Present

    • Switzerland
    • Research Services
    • 1 - 100 Employee
    • Medical Consultant
      • Jul 2021 - Present

    • United Kingdom
    • Research Services
    • 1 - 100 Employee
    • Researcher Expert on COVID -19 for the Knowledge Exchange Unit
      • Apr 2020 - Present

    • Belgium
    • Government Administration
    • 700 & Above Employee
    • External Expert Evaluator
      • May 2017 - Present

    • Spain
    • Venture Capital and Private Equity Principals
    • Senior Advisor
      • Nov 2019 - Present

    • B20 Italy - Health & Life Sciences Task Force - Deputy
      • Feb 2021 - Jul 2021

    • Switzerland
    • Pharmaceutical Manufacturing
    • 1 - 100 Employee
    • AMR commitee member
      • Oct 2018 - Jul 2021

    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Corporate Therapeutic Area Head Infectious Diseases - Clinical Sciences
      • Jun 2014 - Jul 2021

    • Belgium
    • Research Services
    • 1 - 100 Employee
    • AMR SGG group member
      • Apr 2017 - Sep 2019

    • HCV Disease Area Specialist
      • Jun 2013 - May 2014

      Support the HCV drug development implementing a strategical vision of the HCV scenario also through strong relationships with TOP TLs and other external and internal stakeholders.

    • Interim HCV Disease Area Specialist Southern European Hub
      • May 2012 - Jun 2013

    • Virology Medical Science Manager
      • Jan 2005 - Jun 2013

    • Senior MSM Virology
      • 2005 - 2012

    • INTERNAL RESEARCH FELLOW
      • Jan 2001 - Feb 2005

      Experience: - SUB INVESTIGATOR - STUDY COORDINATOR for ISR (Internal Independent Research Program) and for all the INDUSTRY'S SPONSORED clinical trials, from PHASE I (i.e. TMC-125, maraviroc, HIV anti-TAT recombinant "Ensoli" vaccine) to PHASE IV, including large registrative trials for atazanavir, tenofovir, fos-APV, T-20, FTC, TPV . - In 2005, RESPONSIBLE FOR THE ITALIAN SIEROCONVERSION STUDY, directed by the NATIONAL INSTITUTE OF HEALTH (ISS). During this period, gain full understanding of clinical research processes, including GCPs, and specific management skills, also through regular relationship with Sponsor's CTA and SM, ethical committee members, hospital pharmacists head, patients, easily gaining empathy and trust.

    • Infectious Diseases Specialization
      • Oct 1996 - Jan 2001

      DEPARTMENT OF INFECTIOUS DISEASES, directed by Prof Ortona and then Prof Cauda RESIDENT PHYSICIAN MAIN ACTIVITIES: - Responsible for research activities on HIV, TBC and PCP. DEPARTMENT OF INFECTIOUS DISEASES, directed by Prof Ortona and then Prof Cauda RESIDENT PHYSICIAN MAIN ACTIVITIES: - Responsible for research activities on HIV, TBC and PCP.

Education

  • London School of Hygiene and Tropical Medicine, U. of London
    Certificated, COVID-19: TACKLING THE NOVEL CORONAVIRUS
    2020 - 2020
  • National Institute of Infectious Diseases Lazzaro Spallanzani
    Fellowship
    2001 - 2005
  • Università Cattolica del Sacro Cuore
    Medicina e Chirurgia, Infectious Diseases Specialization
    1996 - 2000
  • Università Cattolica del Sacro Cuore
    Dottore in Medicina, medicina e chirurgia- ucsc
    1990 - 1996
  • SCIENTIFIC HIGH SCHOOL
  • Istituto Magistrale "A. Manzoni" Caserta
    Diploma MAGISTRALE
  • Conservatorio "D. Cimarosa" Avellino
    DIPLOMA DI SOLFEGGIO

Community

You need to have a working account to view this content. Click here to join now